. In a combined model, NFL accounted for 3.2% of unique variance in WMHs and Ab 42 accounted for an additional 4.3% beyond NFL, providing novel evidence of the co-occurrence of at least 2 distinct pathways for WMHs among older adults, including amyloid deposition and axonal injury.
Introduction
White matter hyperintensities (WMHs) are nonspecific radiographic markers of fluid accumulation that appear on T2-weighted magnetic resonance imaging (MRI). Prevalent among communitydwelling older adults (Garde et al., 2000; Ylikoski et al., 1995) , WMHs relate to an increased incidence of clinical dementia (Benedictus et al., 2015; Debette et al., 2010; Provenzano et al., 2013) and stroke (Debette et al., 2010) . Cerebral small vessel disease is traditionally the most common etiology attributed to WMHs in older adults (Provenzano et al., 2013) , but emerging evidence suggests multiple pathological pathways are likely (Gouw et al., 2011; Lee et al., 2016) . Among older adults with prodromal and clinical Alzheimer's disease (AD), increased WMHs relate to in vivo amyloid aggregation as measured by positron emission tomography (Grimmer et al., 2012; Kandel et al., 2016; Marnane et al., 2016; Provenzano et al., 2013) and cerebrospinal fluid (CSF) b-amyloid 42 (Ab 42 ) (Marnane et al., 2016) . Increased WMHs are found in autosomal-dominant AD before the onset of clinical symptoms, suggesting a link between WMHs and AD pathophysiology (Lee et al., 2016) . Increased tau aggregation has also been linked to WMHs (Hertze et al., 2013; Marnane et al., 2016; Tosto et al., 2015) , albeit less consistently than amyloid aggregation (Kester et al., 2014; van Westen et al., 2016) . Collectively, these data suggest there may be an AD-specific pathway contributing to WMHs among older adults.
CSF biomarkers have become increasingly recognized for their diagnostic and prognostic utility in the study of AD and related dementia (Olsson et al., 2016) . CSF comes in direct contact with the extracellular compartment of the brain. Therefore, analysis of CSF can provide in vivo information about biochemical changes associated with pathophysiological processes and may enhance insight into the neural correlates of WMHs. Ab 42 and hyperphosphorylated tau (p-tau) are well-established CSF biomarkers associated with AD while total tau (t-tau) is a well-established CSF biomarker of neurodegeneration (Blennow et al., 2010) . Neurofilament light (NFL) is a nondisease-specific CSF biomarker for large-caliber axonal injury (Skillback et al., 2014) . Fig. 1 provides an illustration of the pathophysiology of AD and neuronal injury associated with changes in concentrations for each of these 4 CSF biomarkers of interest (Ab42, p-tau, t-tau, and NFL). Despite emerging evidence that reduced CSF Ab 42 (Kester et al., 2014; Marnane et al., 2016) and increased CSF NFL (Bjerke et al., 2014; Jonsson et al., 2010) may correlate with higher WMHs volume among older adults, it is unknown whether the variance explained by these 2 biomarkers is unique or overlapping. Furthermore, p-tau and t-tau associations with WMHs warrant further investigation given inconsistent findings to date (Kester et al., 2014) .
The present study relates in vivo CSF biomarkers of AD pathophysiology (Ab 42 , p-tau), neurodegeneration (t-tau), and axonal injury (NFL) to fluid-attenuated inversion recovery (FLAIR)eassessed cerebral WMHs. We hypothesized that Ab 42 and NFL would relate to WMHs among older adults. If WMHs reflect heterogeneous ADspecific and noneAD-specific pathophysiological substrates, then biomarkers of AD pathogenesis (Ab 42 ) and noneAD-specific axonal damage (NFL) should account for separate variance in WMHs. Therefore, in secondary analyses, we hypothesized that Ab 42 and NFL would account for unique variance in WMHs. Given the mixed literature regarding p-tau and t-tau associations with WMHs (Kester et al., 2014; Marnane et al., 2016), we hypothesized that p-tau and t-tau would have weak associations with WMHs. The novelty of our work lies in our inclusion of competitive analytical models incorporating both Ab 42 and NFL. These models assess whether each biomarker is associated with WMHs and whether the variance in WMHs accounted for by each biomarker is overlapping or independent of the other. This approach provides a more integrated understanding of the underlying CSF biochemical changes that occur in the context of WMHs among older adults. Our research also adds to emerging evidence linking CSF NFL to brain health outcomes among participant samples enriched for prodromal AD.
Materials and methods

Participants
The Vanderbilt Memory & Aging Project (Jefferson et al., 2016 ) is a longitudinal study investigating vascular health and brain aging in a cohort enriched for mild cognitive impairment (MCI). The inclusion criteria of the cohort required participants be aged 60 years and older, speak English, have adequate auditory and visual acuity for testing, and have a reliable study partner. At enrollment, participants were excluded for MRI contraindication, history of neurological disease (e.g., dementia, multiple sclerosis), stroke, heart failure, major psychiatric illness (e.g., schizophrenia), head injury with loss of consciousness >5 minutes, and systemic or terminal illness (e.g., cancer) that could impact follow-up examination participation. Based on a detailed medical history and record review, clinical interview, and neuropsychological assessment, participants were labeled at baseline with normal cognition (NC), early MCI (Aisen et al., 2010), or MCI (Albert et al., 2011). At enrollment, participants (2) Tau is a protein found on microtubules that form the intracellular neurofibrillary tangles characteristic of AD. Higher CSF concentrations of tau occur in response to neurodegeneration. Hyperphosphorylated tau is measured by marking a specific phosphorylation site on the tau protein. Hyperphosphorylated tau measurements are more specific to Alzheimer's pathology than total tau due to the hyperphosphorylation of tau that occurs in AD. As depicted on panel A, tau may be phosphorylated in its normal state and is involved in the dynamic instability of microtubules. Panel B illustrates how tau proteins become hyperphosphorylated in AD, causing tau to prematurely detach from microtubules and disrupt the balance of assembly and disassembly of microtubules. (3) Neurofilament light is the smallest and most abundant of 3 polypeptides that form neurofilament proteins found in large-caliber, myelinated axons. As depicted in panel A, neurofilaments exist in the axon alongside microtubules, increasing the axon's diameter and conduction velocity. When axonal damage occurs as illustrated in panel B, neurofilaments spill into extracellular space and are cleared as cellular waste into the CSF. Higher CSF concentrations of neurofilament light reflect the acute occurrence of axonal injury. Abbreviation: AD, Alzheimer's disease.
